However, it is essential to consult a healthcare provider to determine if its suitable based on medical history, current health status, and weight loss goals
Notable Studies: Once-Weekly Semaglutide for Weight Management: A Clinical Review Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials Also Known As: Ozempic, Rybelsus, Wegovy, A10BJ06 Research Applications: Anti-obesity and weight loss Glycemic control Cardiovascular health Neuroprotection Risks: Gastrointestinal upset and related reactions Link to thyroid C-cell tumors in rodent studies Contraindicated in Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Risk of acute and chronic pancreatitis FDA approval only for T2D and overweight/obese subjects Chemical Structure What is Semaglutide
A 6-month longitudinal study found that elevated cortisol, insulin resistance, and chronic stress levels were each linked to greater weight gain over time
Semaglutide can cause dehydration, primarily through its gastrointestinal side effects like nausea and vomiting, which in turn can lead to dizziness
It stimulates insulin secretion in a glucose-dependent manner, meaning it works when blood sugar levels are high and reduces activity when levels normalize